Liposome mediated gene transfer.

Dept. of Microbiology & Immunology, Albany Medical College, New York 12208.
BioTechniques (Impact Factor: 2.4). 6(7):682-90.
Source: PubMed

ABSTRACT Liposomes, artificial membrane vesicles, are being intensively studied for their usefulness as delivery vehicles in vitro and in vivo. Substantial progress has been made in the development of procedures for liposome preparation, targeting and delivery of contents. The broad flexibility now available in the design of the structure and composition of liposomes, coupled to recent reports of liposome mediated gene transfer in animals, suggest that liposome technology is now poised to be utilized in the creation of custom-designed cell-type-specific gene transfer vehicles.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Vaccination with plasmid DNA against infectious pathogens including dengue is an active area of investigation. By design, DNA vaccines are able to elicit both antibody responses and cellular immune responses capable of mediating long-term protection. Great technical improvements have been made in dengue DNA vaccine constructs and trials are underway to study these in the clinic. The scope of this review is to highlight the rich history of this vaccine platform and the work in dengue DNA vaccines accomplished by scientists at the Naval Medical Research Center. This work resulted in the only dengue DNA vaccine tested in a clinical trial to date. Additional advancements paving the road ahead in dengue DNA vaccine development are also discussed.
    Vaccine 07/2011; 29(42):7261-6. · 3.77 Impact Factor
  • Journal of Liposome Research 09/2008; 3(2). · 1.91 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Abstract For more than a decade our laboratories have been combining concepts in biochemistry, virology and immunology, in order to develop a conceptual basis for vaccine design. Our long term goals have been to construct simple and well defined immunogens which would stimulate specific immune responses in vivo. Using this approach, we hypothesized that it should be possible to define the structural and biochemical parameters of an immunogen that are necessary and sufficient to stimulate designated effector arms of the immune system. Through the use of covalently coupled peptide complexes, we have been able to define minimal requirements for the induction of humoral immune responses. Minimal requirements for the induction of CD 8 +, MHC Class I restricted Cytotoxic T Lymphocytes have been defined through the use of fusogenic proteoliposomes and simple peptide-lipid complexes (1,2). Finally, we have described a unique, highly stable, lyophilizable, lipid-based vaccine carrier and delivery formulation called protein cochleates. Protein cochleates are highly effective vaccines when given orally or parenterally, generating strong, long term circulating and mucosal, antibody and cell mediated responses, and protection from mucosal challenge with live virus. Our current focus is to combine these concepts and structures to the preparation of subunit vaccines for humans.
    09/2008; 6(2):357-379.